A gene signature can predict risk of MGUS progressing to multiple myeloma

Multiple myeloma is preceded by monoclonal gammopathy of undetermined significance (MGUS). Serum markers are currently used to stratify MGUS patients into clinical risk groups. A molecular signature predicting MGUS progression has not been produced. We have explored the use of gene expression profil...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Fumou, Cheng, Yan, Ying, Jun, Mery, David, Al Hadidi, Samer, Wanchai, Visanu, Siegel, Eric R., Xu, Hongwei, Gai, Dongzheng, Ashby, Timothy Cody, Bailey, Clyde, Chen, Jin-Ran, Schinke, Carolina, Thanendrarajan, Sharmilan, Zangari, Maurizio, Janz, Siegfried, Barlogie, Bart, Van Rhee, Frits, Tricot, Guido, Shaughnessy, John D., Zhan, Fenghuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308756/
https://www.ncbi.nlm.nih.gov/pubmed/37386588
http://dx.doi.org/10.1186/s13045-023-01472-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308756/
https://www.ncbi.nlm.nih.gov/pubmed/37386588
http://dx.doi.org/10.1186/s13045-023-01472-y

Ejemplares similares